Babson Invests in Summit Research Labs

Babson Invests in Summit Research Labs

Babson Capital Management has made an equity co-investment to support One Rock Capital Partners’ acquisition of Summit Research Labs from MVC Capital.

Summit Research Labs is a specialty chemical company that manufactures antiperspirant actives — chemical ingredients that give antiperspirants their sweat-blocking ability – that are sold to large consumer products and personal care products companies. Summit Research Labs is based in Huguenot, NY (

“One Rock Capital Partners is pleased to expand our partnership with Babson Capital through our investment in Summit,” said Tony Lee, Managing Partner at One Rock. “The ability of Babson Capital to provide a comprehensive suite of private finance solutions and its emphasis on strong, long-term sponsor relationships make it an ideal partner for One Rock Capital.”

One Rock makes equity investments of $10 million to $50 million in companies operating in the chemicals, industrial and consumer durables, business services, environmental services, healthcare products, and automotive retail sectors. The firm is based in New York (

“Babson Capital is grateful for the opportunity to partner with One Rock on its investment in Summit,” said Michael Klofas, Managing Director and Head of the U.S. Mezzanine & Private Equity Group. “One Rock’s specialty chemicals experience will enhance its ability to provide operational and strategic support to the management team, and we look forward to participating in Summit’s growth in becoming a leading specialty chemical company serving the personal care industry.”

Babson Capital has $181 billion in assets under management and is a member of the MassMutual Financial Group. The firm has offices in Boston and Springfield, MA, New York, Chicago, Charlotte and Los Angeles and nine other offices in Europe, Asia and Australia (

© 2013 PEPD • Private Equity’s Leading News Magazine • 6-12-13

To search in site, type your keyword and hit enter